McGill University: Discovery Remarkably Improves Immunotherapy in Bladder Cancer and Beyond
June 27, 2025
June 27, 2025
MONTREAL, Quebec, June 27 (TNSjou) -- McGill University issued the following news release:
* * *
New discovery remarkably improves immunotherapy in bladder cancer and beyond
A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours
*
BCG therapy--the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle laye . . .
* * *
New discovery remarkably improves immunotherapy in bladder cancer and beyond
A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours
*
BCG therapy--the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle laye . . .